Ketoconazole 2% shampoo in the treatment of tinea versicolor: A multicenter, randomized, double-blind, placebo-controlled trial

被引:27
|
作者
Lange, DS
Richards, HM
Guarnieri, J
Humeniuk, JM
Savin, RC
Reyes, BA
Hickman, J
Pariser, DM
Pariser, RJ
Sherertz, EF
Grossman, RM
Gisoldi, EM
Klausner, MA
机构
[1] Janssen Pharmaceut, Dept Med Affairs, Titusville, NJ 08560 USA
[2] Upstate Clin Res, Greer, SC USA
[3] Savin Dermatol Ctr, New Haven, CT USA
[4] Int Dermatol Res, Miami, FL USA
[5] Educ & Res Fdn, Lynchburg, VA USA
[6] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[7] Virginia Clin Res, Norfolk, VA USA
[8] Wake Forest Univ, Bowman Gray Sch Med, Dermatol Clin Studies Ctr, Winston Salem, NC USA
[9] Johnson & Johnson Consumer Prod Inc, Skillman, NJ 08558 USA
关键词
D O I
10.1016/S0190-9622(98)70267-1
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Tinea versicolor is a common superficial fungal infection caused by a lipophilic yeast. This chronically recurring opportunistic infection is especially prevalent in tropical and semitropical regions. The topical short-term application of ketoconazole 2% shampoo may provide effective and safe therapy for tinea versicolor. Objective: The purpose of this study was to evaluate the efficacy and safety of a single application (1 day) versus three daily applications (3 days) of ketoconazole 2% shampoo versus placebo shampoo in the treatment of mycologically confirmed tinea versicolor. Methods: Three hundred twelve patients were included in the primary analyses for this 31-day study. Global evaluation scores were measured on days 10 and 31 with a 5-point scale (1 = healed to 5 = worsening), and a cellophane tape test was done at baseline and days 3, 10, and 31. Efficacy was assessed by clinical response, defined as both a global evaluation score of 1 (healed) and a negative cellophane tape test on day 31. Signs and symptoms of tinea versicolor (scaling, itching, erythema, hypopigmentation, hyperpigmentation) also were evaluated at baseline, day 10, and day 31 with a 4-point scale (0 = absent to 3 = severe). Results: Both regimens of ketoconazole shampoo were significantly (P <.001) more effective than placebo for rate of clinical response, global evaluation scores, and mycologic outcomes (cellophane tape test). The clinical response rates at day 31 were 73%, 69%, and 5% for the 3-day ketoconazole, 1-day ketoconazole, and placebo groups, respectively. The difference in the efficacy of the two ketoconazole treatment regimens was not statistically significant. There were no significant differences between any of the treatment groups in the number of patients who experienced adverse events. No serious adverse events occurred and no patient withdrew from the trial prematurely because of an adverse event. Conclusion: Ketoconazole 2% shampoo, used as a single application or daily for 3 days, is safe and highly effective in the treatment of tinea versicolor.
引用
收藏
页码:944 / 950
页数:7
相关论文
共 50 条
  • [1] DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF KETOCONAZOLE AS A SINGLE TOPICAL APPLICATION IN THE TREATMENT OF TINEA-VERSICOLOR
    REKACEWICZ, I
    GUILLAUME, JC
    BENKHRABA, F
    ARCHIMBAUD, A
    BASPEYRAS, M
    BOITIER, F
    BUSSIERE, M
    COIN, A
    DICREZENZO, MC
    DUVAL, J
    EVENOU, P
    GIROUIN, D
    INTERLIGATOR, D
    LICHTENBERG, JP
    OEHMICHEN, O
    PATTIER, P
    POLI, F
    POUGET, F
    CHWETZOFF, E
    REVUZ, J
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1990, 117 (10): : 709 - 711
  • [2] Gabapentin in the treatment of fibromyalgia - A randomized, double-blind, placebo-controlled, multicenter trial
    Arnold, Lesley M.
    Goldenberg, Don L.
    Stanford, Sharon B.
    Lalonde, Justine K.
    Sandhu, H. S.
    Keck, Paul E., Jr.
    Welge, Jeffrey A.
    Bishop, Fred
    Stanford, Kevin E.
    Hess, Evelyn V.
    Hudson, James I.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (04): : 1336 - 1344
  • [3] DOUBLE-BLIND COMPARISON OF 2-PERCENT KETOCONAZOLE CREAM AND PLACEBO IN THE TREATMENT OF TINEA VERSICOLOR
    SAVIN, RC
    HORWITZ, SN
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 15 (03) : 500 - 503
  • [4] SUCCESSFUL TREATMENT AND PROPHYLAXIS OF SCALP SEBORRHEIC DERMATITIS AND DANDRUFF WITH 2-PERCENT KETOCONAZOLE SHAMPOO - RESULTS OF A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    PETER, RU
    RICHARZBARTHAUER, U
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1995, 132 (03) : 441 - 445
  • [5] Individualized Homeopathic Medicines in the Treatment of Tinea Corporis: Double-Blind, Randomized, Placebo-Controlled Trial
    Laskar, Bakibillah
    Paul, Swapan
    Chattopadhyay, Abhijit
    Karuppusamy, Avaranjika
    Balamurugan, Dharshna
    Bhakta, Puja
    Das, Sourav
    Pal, Siddhartha
    Singh, Navin Kumar
    Koley, Munmun
    Saha, Subhranil
    [J]. HOMEOPATHY, 2023, 112 (02) : 74 - 84
  • [6] A Double-Blind Randomized Placebo-Controlled Clinical Trial of Squalamine Ointment for tinea capitis Treatment
    Oumar Coulibaly
    Mahamadou A. Thera
    Abdoulaye K. Koné
    Goïta Siaka
    Pierre Traoré
    Abdoulaye A. Djimdé
    Jean-Michel Brunel
    Jean Gaudart
    Renaud Piarroux
    Ogobara K. Doumbo
    Stéphane Ranque
    [J]. Mycopathologia, 2015, 179 : 187 - 193
  • [7] A Double-Blind Randomized Placebo-Controlled Clinical Trial of Squalamine Ointment for tinea capitis Treatment
    Coulibaly, Oumar
    Thera, Mahamadou A.
    Kone, Abdoulaye K.
    Siaka, Goita
    Traore, Pierre
    Djimde, Abdoulaye A.
    Brunel, Jean-Michel
    Gaudart, Jean
    Piarroux, Renaud
    Doumbo, Ogobara K.
    Ranque, Stephane
    [J]. MYCOPATHOLOGIA, 2015, 179 (3-4) : 187 - 193
  • [8] Flutrimazole shampoo 1% ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial
    Rigopoulos, D.
    Gregoriou, S.
    Kontochristopoulos, G.
    Ifantides, A.
    Katsambas, A.
    [J]. MYCOSES, 2007, 50 (03) : 193 - 195
  • [9] Pentoxifylline in ALS: A double-blind, randomized, multicenter, placebo-controlled trial
    Levin, B
    Thompson, JLP
    Levy, G
    Mitsumoto, H
    Kaufmann, P
    [J]. NEUROLOGY, 2006, 66 (11) : 1786 - 1786
  • [10] Pentoxifylline in ALS - A double-blind, randomized, multicenter, placebo-controlled trial
    Meininger, V
    Asselain, B
    Guillet, P
    Leigh, PN
    Ludolph, A
    Lacomblez, L
    Robberecht, W
    [J]. NEUROLOGY, 2006, 66 (01) : 88 - 92